Adele Bari
Chronic kidney disease (CKD) affects millions of people worldwide and is a major cause of morbidity and mortality. In some cases, the underlying cause of CKD, known as nephropathy, is unknown, presenting a diagnostic challenge for clinicians. However, recent advances in genetic screening techniques have shed light on the genetic factors that contribute to kidney disease, offering new insights into the diagnosis and treatment of CKD, particularly in the context of kidney transplantation. In this article, we explore the role of genetic screening in patients with unknown nephropathy and its implications for kidney transplantation.
分享此文章